The ever-evolving digital world is transforming the pharmaceutical landscape. This creates unique opportunities for small to mid-sized pharmaceutical companies. The key is to establish true omnichannel connectivity. Dr. Martin Kamleiter-Borski, a Partner with a-connect’s Life Sciences Practice, explains four key steps in achieving omnichannel excellence.
This article details the four key steps to achieving digital omnichannel excellence:
By doing so small to mid-sized pharmaceutical companies can Enhance their market presence and provide customers physicians, pharmacists, patients, payors, policymakers) more tailored and engaging experiences.
The rationale is clear. Leadership provides vision and direction. Cross-functional collaboration brings diverse expertise to the table. This helps facilitate comprehensive problem-solving and innovative thinking. Let’s delve deeper into these critical components.
They’ll need industry experience and a flair for innovative thinking to set the vision and steer transformation. Your COO champions the cause, aligns it with broader corporate objectives, and:
The choice should align with post-merger scenario strategic goals as well as the merger tax plan.
Build a core multi-disciplinary innovation team, ensuring it:
At the heart of this endeavor lies a relentless and non-negotiable commitment to the customer. Every decision, from technology investments to content creation, must be guided by a deep understanding of customer needs and preferences.
Traditional project management methodologies often falter in the face of rapid change. Agile encourages adaptability and responsiveness. It also makes it easier for people to see progress. This is ideal for Omnichannel activities and transformations.
But using these key principles can increase efficiency, and inclusion, and help the team shine:
Small and mid-sized pharmaceutical companies often operate globally through local affiliates. These are well-positioned to provide insights into regional nuances, market trends, and customer behaviors. This includes:
Effective collaboration enhances your omnichannel strategy’s relevance and success. And, never forget that most of the customer-facing functions work on an affiliate level.
Always conduct a thorough assessment and prioritization of existing digital initiatives. You can then understand what’s in place and select initiatives that deliver maximum impact. Additionally, mapping activities across functions, tiers and geographies helps get your organization onboard and enables local teams to shine
Catalog and assess existing digital initiatives, making sure you consider:
This will ensure resources are channeled effectively and should consider:
Once you’ve identified and prioritized initiatives, select those with the potential for regional and international scalability. Use the following three criteria for selecting initiatives:
Scalability is a key determinant for long-term success. So, it’s vital you invest time in this area.
A carefully built operating model is key to coping with the intricacies of data, people, and systems working together. It gives you the ability to:
This is essential given the many layers of the pharmaceutical industry and challenges to functioning omnichannel.
This puts insights at your fingertips. So, create a hub that aggregates customer data, to provide a comprehensive view of customer behavior and preferences. These insights are invaluable for tailoring digital content and engagement strategies. Your hub should:
Localization enhances customer engagement, but it must be:
From social media to websites and mobile apps, seamless integration is key to delivering a consistent customer experience. When integrating channels ensure:
Real-time performance monitoring is critical. Your regional analytics center must continuously assess the impact of digital initiatives. And the insights need to inform ongoing optimization. It’s vital that your analytics center:
Regulatory requirements in the pharmaceutical industry are stringent and vary by region. Stay abreast of regional compliance and regulatory changes. Implement a robust compliance framework to ensure adherence across all digital touchpoints, this must include:
The path to creating and implementing successful omnichannel strategies lies in:
We believe that being conscious of these four catalysts helps pharmaceutical firms to successfully navigate the complex digital landscape. And ultimately this unlocks the full potential of intelligent inter-channel connectivity to:
Discover how we can help accelerate your journey to omnichannel excellence today.
Dr. Martin Kamleiter-Borski is a Client Service Partner within a-connect’s Life Sciences Practice. Martin is a seasoned Life Sciences and Healthcare expert who leverages his deep expertise of many years of hands-on experience in the pharmaceutical industry to assist clients in mastering the challenges of change, evolution, and disruption in this dynamic ecosystem. Martin joined a-connect in 2021, and is a physician with a doctorate in neurosciences from Ludwig-Maximilians-University Munich, Germany. His extensive background includes research, clinical psychiatry, and consulting with EY. His primary areas of focus are Commercial Excellence, Innovative Business Models, and Digital Therapeutics.
Insights
More Insights chevron_right